Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins / tetracycline / iv dye, iodine containing contrast media attending: chief complaint: desensitization major surgical or invasive procedure: none history of present illness: ms. is a 63f with stage iiic poorly differentiated primary peritoneal serous carcinoma, now with disease recurrence and participating in a clinical trial, admitted to the icu for cycle 6 of /taxol therapy with carboplatin desensitization. one third of the way through infusion of carboplatin during cycle 2 of chemotherapy on , she developed an intense feeling of heat and generalized body tingling, numbness and tingling of the lips, and chest tightness. carboplatin was discontinued and she received 100 mg hydrocortisone and 50 mg of benadryl iv. her vital signs remained stable, but she later had vomiting and headache. given her allergic reaction, she was admitted to the icu to receive cycles 3 and 4 of carboplatin per the desensitization protocol. she has tolerated the treatments without incident. she was readmitted to the icu earlier this month for desensitization for cycle 5 again without incident. today, she is directly admitted to the icu again for carboplatin desensitization for cycle 6 of chemotherapy. on arrival to the micu, patient's vs: 97.8, 85, 131/78, 18, 100% ra review of systems: (+) per hpi (-) denies fever, chills, night sweats, recent weight loss or gain. denies headache, sinus tenderness, rhinorrhea or congestion. denies shortness of breath, cough, or wheezing. denies chest pain, chest pressure, palpitations. denies constipation, abdominal pain, diarrhea, dark or bloody stools. denies dysuria, frequency, or urgency. denies arthralgias or myalgias. denies rashes or skin changes. past medical history: - stage iiic poorly differentiated primary peritoneal serous carcinoma - thalassemia - hypertension (per patient never treated with home medication, only when in hospital or seeing doctors) - gastritis/reflux oncologic history - ct abd/pelvis on revealed a large mass centered in the sigmoid colon with pelvic lymphadenopathy, retroperitoneal lymphadenopathy, and peritoneal carcinomatosis. - a colonoscopy revealed a fungating, ulcerated mass within the sigmoid colon causing a partial obstruction. the biopsy of this mass revealed adenocarcinoma with papillary formation, suggestive of an ovarian primary. - underwent exploratory laparotomy, hysterectomy, bilateral salpingo-oophorectomy, rectosigmoid resection with colorectal re anastomosis and diverting loop ileostomy. this was a suboptimal tumor debulking. intra-operatively, the uterus and bilateral adnexal were unremarkable. extensive firm retroperitoneal lymphadenopathy was appreciated. there was no evidence of carcinomatosis. the tumor was noted to involve the sigmoid colon and rectum. pathology examination revealed serous carcinoma involving full thickness of the rectal wall. seven of eight lymph nodes were positive for malignancy. uterus, cervix, fallopian tubes, and ovaries were negative for malignancy. - : 5 cycles of chemotherapy with carboplatin q21 days and weekly taxol, 6th cycle of chemotherapy with carboplatin and taxotere in place of taxol due to neurotoxicity - : mri of the l-spine shows new retroperitoneal lymphadenopathy consistent with disease recurrence. - started chemotherapy according to the clinical trial #11-228 (phase ii, multi-center, double-blind, placebo controlled, randomized study of ombrabulin in patients with platinum-sensitive recurrent ovarian cancer treated with carboplatin/paclitaxel) social history: immigrated from in youth. formerly employed in retail sales. no children, husband lives in . sister and live in area. - tobacco: never - etoh: denies - illicits: denies family history: mother and father lived to their 70s. family history of thalassemia. uncle with diabetes. she denies family history of cancer, cad, or hypertension. physical exam: admission exam: vitals: 122/75 hr 84 95%/ra general: alert, oriented, well appearing female pleasant in no acute distress heent: sclera anicteric, mmm, oropharynx clear, eomi, perrl, edentulous with top dentures in place neck: supple, jvp not elevated, no lad cv: regular rate and rhythm, normal s1 + s2, no murmurs, rubs, gallops lungs: clear to auscultation bilaterally, no wheezes, rales, rhonchi abdomen: soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding gu: no foley ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema neuro: cnii-xii intact, 5/5 strength upper/lower extremities, grossly normal sensation discharge exam: tmax: 37 ??????c (98.6 ??????f) tcurrent: 36.6 ??????c (97.9 ??????f) hr: 68 (68 - 93) bpm bp: 117/62(76) {99/51(63) - 138/80(90)} mmhg rr: 17 (15 - 23) insp/min spo2: 96% heart rhythm: sr (sinus rhythm) general: alert, oriented, well appearing female pleasant in no acute distress heent: sclera anicteric, mmm, oropharynx clear, eomi, perrl, edentulous with top dentures in place neck: supple, jvp not elevated, no lad cv: regular rate and rhythm, normal s1 + s2, rusb 2/6 systolic ejection murmur, no rubs or gallops lungs: clear to auscultation bilaterally, no wheezes, rales, rhonchi abdomen: soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding gu: no foley ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema neuro: cnii-xii intact, 5/5 strength upper/lower extremities, grossly normal sensation pertinent results: admission labs: 08:45am blood wbc-4.4 rbc-3.65* hgb-8.4* hct-26.3* mcv-72* mch-23.1* mchc-32.0 rdw-20.7* plt ct-188 08:45am blood neuts-49.1* lymphs-42.2* monos-6.3 eos-1.7 baso-0.7 08:45am blood pt-10.8 inr(pt)-1.0 08:45am blood plt ct-188 08:45am blood urean-18 creat-0.8 na-142 k-3.8 cl-106 08:45am blood glucose-110* 08:45am blood alt-39 ast-36 alkphos-111* totbili-0.3 dirbili-0.1 indbili-0.2 08:45am blood totprot-7.4 albumin-4.4 globuln-3.0 calcium-9.6 phos-3.5 mg-1.5* 08:45am blood ca125-41* 08:42am urine color-straw appear-clear sp -1.003 08:42am urine blood-neg nitrite-neg protein-neg glucose-neg ketone-neg bilirub-neg urobiln-neg ph-5.0 leuks-neg 08:42am urine hours-random creat-20 totprot-<6 discharge labs: 06:14am blood wbc-7.0 rbc-3.46* hgb-7.9* hct-25.0* mcv-72* mch-22.7* mchc-31.4 rdw-20.8* plt ct-172 06:14am blood glucose-124* urean-24* creat-0.9 na-141 k-4.1 cl-106 hco3-27 angap-12 01:30pm blood alt-38 ast-33 ld(ldh)-253* alkphos-102 totbili-0.3 06:14am blood calcium-8.4 phos-4.1 mg-1.7 pertinent micro: none pertinent imaging: none brief hospital course: 64f with history of stage iiic primary peritoneal carcinoma who presents for desensitization to carboplatin prior to cycle # 6 of treatment with paclitaxel and carboplatin. active issues: # carboplatin allergy: patient has a history of reaction to treatment (heat and generalized body tingling, numbness and tingling of the lips, and chest tightness) during cycle 2 of treatment. has subsequently undergone desensitization prior to treatment for cycles without incident. presented for desensitization today prior to cycle 6. desensitization protocol was implemented per pharmacy/oncology recs (protocol prepared by pharmacy, signed by oncology as this is chemotherapy not ordered by housestaff). the patient was premedicated 30-60 minutes prior to initiation of chemotherapy with the following: diphenhydramine 25 mg iv, famotidine 20 mg iv, ondansetron 8 mg iv, dexamethasone 10 mg iv. chemotherapy (desensitization to carboplatin): paclitaxel 330.8 mg iv, carboplatin 5.897 mg iv, carboplatin 58.97 mg iv, carboplatin 589.7 mg iv (full therapeutic dose). she did not require any epinephrine and did not exhibit signs or sx of an allergic reaction. the patient tolerated desensitization well and had no adverse reactions. # stage iiic primary peritoneal serous carcinoma: patient currently undergoing chemotherapy as above; oncology history as above. plan for outpatient ct scan for re-staging on with premedication for contrast allergy. inactive issues: # thalassemia: stable, no changes # hypertension ("white coat;" not on treatment): stable, no treatment required # status post cholecystectomy: asymptomatic, stable # gastritis/reflux: stable transitional issues: # chemo: patient should be followed closely for any reactions medications on admission: - dexamethasone as directed - vicodin 5-500 mg tablet(s) by mouth q4-6 hours as needed for pain (up to 8 tablet) - lorazepam 0.5 mg tablet tablet(s) by mouth every eight (8) hours as needed for nausea or anxiety - ondansetron hcl 8 mg by mouth twice daily as needed for nausea - prednisone 50 mg tablet: take 1 tablet 13, 7 and 1 hour prior to ct scan - prochlorperazine maleate 10 mg tablet by mouth twice daily x 3 days after chemotherapy - diphenhydramine -cap 25 mg capsule 2 capsule(s) by mouth once 1 hour prior to ct scan - colace - senna discharge medications: 1. docusate sodium 100 mg po bid 2. lorazepam 0.5 mg po q8h:prn anxiety 3. ondansetron 8 mg po q8h:prn nausea 4. senna 1 tab po bid:prn constipation discharge disposition: home discharge diagnosis: primary diagnosis: - chemotherapy desensitization - peritoneal serous carcinoma discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: ambulatory - independent. discharge instructions: dear mrs. , it was a pleasure caring for you while you were hospitalized at the . as you recall, you were admitted for desensitization to one of your chemotherapeutic agents. you tolerated this well without any allergic event. there is no change to your medications. please follow up with your doctors below. followup instructions: department: hematology/oncology when: monday at 8:45 am with: checkin hem onc cc9 building: sc clinical ctr campus: east best parking: garage department: hematology/oncology when: monday at 9:30 am with: , rn building: sc clinical ctr campus: east best parking: garage department: cardiac services when: monday at 9:00 am with: echocardiogram building: sc clinical ctr campus: east best parking: garage md procedure: injection or infusion of cancer chemotherapeutic substance diagnoses: esophageal reflux need for desensitization to allergens examination of participant in clinical trial secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes encounter for antineoplastic chemotherapy malignant neoplasm of specified parts of peritoneum thalassemia, unspecified 

Answer: The patient is high likely exposed to